Enoxaparin: all 187 studies that test it

Page 1 of 2. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent MiscarriagesNot yet recruitingNCT07796737Phase 3
• Prophylactic Anticoagulation for Central Venous Line Insertion in Critically Ill ChildrenRecruitingNCT07710482Not applicable
• Study to Determine the Comparative Pharmacodynamics of Enoxaparin Sodium Biosimilar With That From ClexaneNot yet recruitingNCT07517289Phase 1
• Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth RestrictionNot yet recruitingNCT07462182Not applicable
• Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT PreventionRecruitingNCT07243080Phase 4
• Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).Not yet recruitingNCT06628778Phase 3
• Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S DeficiencyNot yet recruitingNCT06531525Phase 2
• Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO SupportRecruitingNCT06442267Phase 4
• Low-Dose Enoxaparin in PsoriasisNot yet recruitingNCT06416566Not applicable
• Thromboprophylaxis in Lower Limb ImmobilisationRecruitingNCT06370273Phase 3
• Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion ChemotherapyRecruitingNCT06293287Phase 2
• Lovenox With Aspirin in Thawed Blastocyst TransferRecruitingNCT06133803Phase 4
• Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot ProjectRecruitingNCT06004674Phase 2
• A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).RecruitingNCT05895136Phase 2
• THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingNCT05735639Phase 4
• STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingNCT05255003Phase 4
• Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingNCT05245877Phase 4
• Catheter-Related Early Thromboprophylaxis With Enoxaparin StudiesRecruitingNCT04924322Phase 2/3
• Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)RecruitingNCT04861103Phase 4
• LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)Enrolling by invitationNCT04762992Phase 3
• LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyEnrolling by invitationNCT03244020Phase 4
• Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)RecruitingNCT02342444Phase 4
• Use of Warfarin After the First Trimester in Pregnant Women With APSRecruitingNCT02303171Phase 4
• Low Molecular Weight Heparin or no Treatment Following Cesarean DeliveryCompletedNCT06118957Phase 2Results posted
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTECompletedNCT04505774Phase 4Results posted
• Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients TrialCompletedNCT04409834Phase 4Results posted
• Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 PatientsCompletedNCT04401293Phase 3Results posted
• Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19CompletedNCT04367831Phase 4Results posted
• COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) TrialCompletedNCT04354155Phase 2Results posted
• Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee ReplacementCompletedNCT03812328Phase 2Results posted
• Below Knee DVT StudyTerminatedNCT03805672Phase 4Results posted
• Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)CompletedNCT03551730Phase 2Results posted
• Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)CompletedNCT03532139Phase 2Results posted
• Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic TraumaCompletedNCT03339349Phase 2Results posted
• Residual Anti-Xa Activity After Last Treatment Dose of EnoxaparinTerminatedNCT03296033Phase 4Results posted
• Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) TrialTerminatedNCT03003390Phase 2Results posted
• A Different Approach to Preventing ThrombosisCompletedNCT02774265Phase 3Results posted
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
• Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer PatientsCompletedNCT02706249Phase 2Results posted
• Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma PatientsCompletedNCT02412982Phase 4Results posted
• Enoxaparin Metabolism in Reconstructive Surgery PatientsCompletedNCT02411292Phase 2Results posted
• Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.CompletedNCT02232802Phase 1Results posted
• A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting ConditionsCompletedNCT02081950Phase 1Results posted
• Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin ThromboprophylaxisCompletedNCT02070237Phase 1Results posted
• Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related ThrombosisCompletedNCT01999179Not applicableResults posted
• Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue TumorsTerminatedNCT01965002Not applicableResults posted
• Enoxaparin Dosing in ObesityCompletedNCT01798550Phase 4Results posted
• Enoxaparin Versus Aspirin in Patients With Cancer and StrokeCompletedNCT01763606Not applicableResults posted
• Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic OncologyCompletedNCT01696760Not applicableResults posted
• PREvention of VENous Thromboembolism In Hemorrhagic Stroke PatientsTerminatedNCT01573169Phase 3Results posted
• Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid SyndromeCompletedNCT01051778Phase 2Results posted
• Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)CompletedNCT01014403Phase 1Results posted
• Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing MicroparticlesCompletedNCT00908960Phase 2Results posted
• Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.CompletedNCT00878826Phase 2/3Results posted
• Enoxaparin and/or Minocycline in Acute StrokeTerminatedNCT00836355Not applicableResults posted
• Clot Dissolving Treatment for Blood Clots in the LungsTerminatedNCT00680628Phase 3Results posted
• Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With CancerTerminatedNCT00633061Phase 2Results posted
• Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVTCompletedNCT00585182Phase 4Results posted
• Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientsTerminatedNCT00521885Not applicableResults posted
• Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic CancerTerminatedNCT00426127Phase 2Results posted
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)CompletedNCT00423319Phase 3Results posted
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary EmbolismCompletedNCT00413374Not applicableResults posted
• Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)CompletedNCT00375609Phase 2Results posted
• Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative VitreoretinopathyActive, not recruitingNCT07787377Not applicable
• A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy ParticipantsCompletedNCT07312851Phase 1
• The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.CompletedNCT06795698Phase 2
• Efficacy of Aspirin in Preventing Venous ThromboembolismCompletedNCT06635317Phase 4
• Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS PatientsCompletedNCT06114641Phase 4
• Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled TrialCompletedNCT05878899Phase 3
• Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19CompletedNCT05311813Not applicable
• Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human SubjectsCompletedNCT05265676Phase 1
• Efficacy and Safety for Different Regimen of VTE Pharmacoprophylaxis Among Severely Burn PatientsCompletedNCT05237726Not applicable
• Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical ProceduresTerminatedNCT05081375Phase 4
• Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19CompletedNCT04646655Phase 3
• Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)CompletedNCT04640181Phase 2
• Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.TerminatedNCT04558892Phase 2/3
• Enoxaparin Bioequivalence Study in Acute Coronary Syndrome PatientsCompletedNCT04552067Phase 1
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 InfectionStatus unknownNCT04528888Phase 3
• Concentration-effect Relationship of Enoxaparin for Thromboembolic PreventionWithdrawnNCT04520620Phase 4
• Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 InfectionStatus unknownNCT04508439Not applicable
• Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive PatientsTerminatedNCT04492254Phase 3
• Australasian COVID-19 Trial (ASCOT) ADAptive Platform TrialActive, not recruitingNCT04483960Phase 3
• Efficacy of Apixaban in Malignancy With Deep Venous ThrombosisStatus unknownNCT04462003Phase 3
• Enoxaparin in COVID-19 Moderate to Severe Hospitalized PatientsCompletedNCT04427098Phase 2
• High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and CoagulopathyStatus unknownNCT04408235Phase 3
• Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19TerminatedNCT04400799Phase 3
• Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19Status unknownNCT04377997Phase 2
• Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19CompletedNCT04373707Phase 4
• Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 PatientsCompletedNCT04366960Phase 3
• Preventing COVID-19 Complications With Low- and High-dose AnticoagulationTerminatedNCT04345848Phase 3
• Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean DeliveryCompletedNCT04305756Not applicable
• Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs RivaroxabanStatus unknownNCT04169269Phase 4
• Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCICompletedNCT03664180Phase 4
• Prolonged Enoxaparin in Primary Percutaneous Coronary InterventionCompletedNCT03568838Phase 4
• Enoxaparin in the Prevention of Placental Insufficiency in Pregnant WomenCompletedNCT03528967Phase 4
• Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy VolunteersCompletedNCT03363477Phase 1
• Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal CancerStatus unknownNCT03254511Phase 2
• Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal FunctionCompletedNCT03158792Phase 4
• Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic StudyCompletedNCT03146858Phase 4
• Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)CompletedNCT03145675Phase 4

← Enoxaparin overview